Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560609 · ClinicalTrials.gov registry record · NA
Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03560609 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 3 participants.
The verdict
NCT03560609, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased Intraocular Pressure (IOP) is a major risk factor. It is also thought that the lamina cribrosa (LC) is a site of primary damage during the pathogenesis of the disease. The changes caused by intraocular pressure (IOP) modulation at the level of the optic nerve head and LC will be evaluated in the present study. Subjects with keratoconus exhibit abnormal collagen properties that can impair their LC behavior. By evaluating their lamina biomechanical response we can advance our understanding on the role of the lamina in glaucoma pathogenesis. A better understanding of the process will ultimately lead to improved detection and management of glaucoma. It is hypothesized that subjects with keratoconus have an abnormal biomechanical response of the lamina cribrosa in response to IOP modulation.
Interventions
- DEVICE Optical Coherence Tomography (OCT)
- DEVICE Ophthalmodynamometer
- DEVICE Goldmann applanation tonometer
- DEVICE Pentacam
- DEVICE ORA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-11-15 |
| Est. Completion | 2024-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03560609
The ClinicalTrials.gov registry entry for NCT03560609 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Optical Coherence Tomography (OCT) is the first listed.
NCT03560609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03560609 about?
NCT03560609 is a clinical study titled "Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus". The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased Intraocular Pressure (IOP) is a major risk factor. It is also thought that the lamina cribrosa (LC) is a site of primary damage during the pathogenesis of the disease. The changes caused by intraoc...
What is the current status of trial NCT03560609?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2018-11-15. Estimated completion is 2024-01-19.
What interventions are being tested in trial NCT03560609?
The interventions under investigation include: Optical Coherence Tomography (OCT) (DEVICE), Ophthalmodynamometer (DEVICE), Goldmann applanation tonometer (DEVICE), Pentacam (DEVICE), ORA (DEVICE).
Who is sponsoring clinical trial NCT03560609?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.